---
category: news
title: "Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at 4th Global NASH Congress"
excerpt: "Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on Artificial Intelligence- driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis and liver disease,"
publishedDateTime: 2021-04-29T13:50:00Z
originalUrl: "https://www.nasdaq.com/press-release/hepion-pharmaceuticals-presents-machine-learning-learn-and-confirm-modeling-strategy"
webUrl: "https://www.nasdaq.com/press-release/hepion-pharmaceuticals-presents-machine-learning-learn-and-confirm-modeling-strategy"
type: article
quality: 27
heat: 27
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - Machine Learning
  - AI

related:
  - title: "Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at 4th ..."
    excerpt: "Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”) - driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and liver disease,"
    publishedDateTime: 2021-04-29T13:52:00Z
    webUrl: "https://apnews.com/press-release/globe-newswire/business-health-coronavirus-technology-87219646d2d65bc37f996c264e72bef7"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 26
    images:
      - url: "https://apnews.com/images/PaidContent3.png"
        width: 700
        height: 450
        isCached: true
  - title: "Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform"
    excerpt: "Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (\"A.I.\")"
    publishedDateTime: 2021-05-03T11:00:00Z
    webUrl: "https://www.prnewswire.com/news-releases/lantern-pharma-and-actuate-therapeutics-announce-research--development-collaboration-leveraging-lanterns-artificial-intelligence-platform-301282027.html"
    type: article
    provider:
      name: PR Newswire
      domain: prnewswire.com
    quality: 3
    images:
      - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg?p=facebook"
        width: 939
        height: 491
        isCached: true

secured: "Ed6TUH8gZjIsF2A5PYQsKKyV9zvPlpFiIhfJynCoOm8L9YtyzLfA12InWEgIY8uFVUEmmOkbLe/oZxMfIgEAkFEQ0B9LYwX4+I17gMXXeqOM81adKwXxMkM1Vo63O1kNEsNEgtzB/ckEoAuiyMCZjn3SuQzDI4SZxOZF2bi/Tme3XEW4bSZH8k33s3jdd1WmC8N/Olhtgbi/Jqu/BnCUkFmV01oT110f6TBAfSeUzfrXEIP7P8KoB1a52FZiom/W+klK4hRyWprHAobONoIwN93CnbQcdR7fYKinIIZ5A3AFZDJUwgIp/c/T/cb9nO1+qqNdpXBTWbmM2ox9i888W6CBP1KCBsoJVSoP3eYnkG4=;WTDG15MBwHjQQH284Z++zg=="
---

